REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $584 | -21.9% | 5,732 | -30.4% | 0.00% | -25.0% |
| Q1 2023 | $748 | +172.0% | 8,232 | +13.8% | 0.00% | +100.0% |
| Q4 2022 | $275 | -100.0% | 7,232 | +22.6% | 0.00% | -33.3% |
| Q3 2021 | $594,000 | -28.9% | 5,900 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $835,000 | +64.4% | 5,900 | +15.7% | 0.00% | +33.3% |
| Q1 2021 | $508,000 | -19.4% | 5,100 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $630,000 | -6.2% | 5,100 | -26.1% | 0.00% | -20.0% |
| Q3 2020 | $672,000 | -92.0% | 6,900 | -87.2% | 0.01% | -86.1% |
| Q2 2020 | $8,394,000 | +315.3% | 53,800 | +284.3% | 0.04% | -18.2% |
| Q1 2020 | $2,021,000 | -34.1% | 14,000 | -6.7% | 0.04% | -17.0% |
| Q4 2019 | $3,066,000 | – | 15,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |